Data spotlight: Sale of Vantage Oncology leads VC-backed M&A in April


Venture fund performance
Counting out cash. REUTERS/Steve Marcus
The venture-backed M&A tally increased in April over March, thanks to Vantage Oncology being acquired by McKesson Specialty Health for more than $1.2 billion. Vantage, which develops and operates radiation oncology treatment centers, had raised $114.5 million in funding from investors ...

This content is available for Venture Capital subscribers only. Request a free trial to get access for a limited period

Venture Capital

Subscribe Now Request Trial

If you already have an active Venture Capital subscription, please sign in to view this article.